Latest / Deep Dive Ortho — Orthopaedic Surgery, AI & Digital Health Podcast. / Partial Cuff repair vs Superior capsule reconstruction

Transcript

Partial Cuff repair vs Superior capsule reconstruction · Deep Dive Ortho — Orthopaedic Surgery, AI & Digital Health Podcast.

• 0:00
  Rotator cuff tears. They're incredibly common,
• 0:03
  aren't they? Especially, well, as we get older.
• 0:05
  They certainly are. A very frequent issue we
• 0:07
  see. But what happens when it's not just a simple
• 0:10
  tear? When it's, you know, massive? Maybe even
• 0:14
  irreparable. Yes, causing significant pain, limiting
• 0:17
  arm function quite severely. We're talking about
• 0:19
  tears involving multiple tendons or just very
• 0:22
  large ones, maybe bigger than five centimeters.
• 0:24
  Exactly. And that can lead to some... quite concerning
• 0:27
  secondary problems like muscle wasting atrophy
• 0:31
  and fat building up within the shoulder muscles.
• 0:33
  And this isn't a rare problem, is it? It affects
• 0:35
  a fair number of people, particularly over 60.
• 0:38
  That's right, a significant percentage. And while
• 0:40
  we always start conservatively... Physio, injections,
• 0:44
  that sort of thing. Precisely. Non -surgical
• 0:46
  options first. But for these larger, more complex
• 0:49
  tears, surgery often becomes, well, necessary.
• 0:53
  And the aim of the surgery, then? Fundamentally,
• 0:56
  it's about trying to restore some functional
• 0:58
  mechanics to the shoulder joint. Give it back
• 1:00
  some stability. Right. And for these really tricky
• 1:03
  cases, the massive irreparable ones where a standard
• 1:06
  repair just isn't on the cards, surgeons have
• 1:09
  different approaches. Yes. Different techniques
• 1:11
  have been developed. So today we're taking a
• 1:13
  deep dive into a recent meta -analysis. It was
• 1:17
  looking specifically at comparing two of these
• 1:19
  surgical options, wasn't it? Correct. Comparing
• 1:22
  partial repair or PR, and superior capsular reconstruction,
• 1:27
  known as SCR. OK, let's break those down a bit.
• 1:30
  Partial repair, PR. Partial repair is essentially
• 1:33
  about, well, working with what's left of the
• 1:36
  rotator cuff. You aim to balance the remaining
• 1:38
  forces around the joint. To try and create a
• 1:40
  stable pivot point. Exactly. So the patient can
• 1:43
  hopefully regain some useful movement and function.
• 1:46
  It's a pragmatic approach, really. OK. And the
• 1:48
  other one, superior capsular reconstruction,
• 1:50
  SCR. SCR is a More reconstructive, it usually
• 1:54
  involves using a graft material. A graft? Like
• 1:57
  what? It could be donor skin tissue, an allograft,
• 1:59
  or sometimes fascia from the patient's own thigh.
• 2:02
  Autograft. This creates a new layer on top of
• 2:04
  the joint. And the point of that is? The idea
• 2:07
  is to restore that crucial superior stability.
• 2:11
  That's what's lost when the upper part of the
• 2:13
  cuff is completely torn and retracted. This SCR
• 2:16
  technique was first described. back in 2012.
• 2:19
  And both TR and SCR are seen as acceptable options.
• 2:23
  Yes, they're both in the surgical toolkit for
• 2:25
  these difficult situations. But the big question
• 2:27
  is, how do they actually stack up against each
• 2:30
  other in practice? Is one better? That's the
• 2:33
  key question, isn't it? And that's what this
• 2:35
  paper set out to address directly. Their goal
• 2:37
  was to compare the results, pooling data from
• 2:40
  existing studies. Correct. Something that hadn't
• 2:42
  been done in quite this specific comparative
• 2:44
  way before. And you're here to help us unpack
• 2:47
  what they found, and crucially, what it really
• 2:49
  means. Absolutely. It's quite fascinating because
• 2:51
  although both techniques have been used for a
• 2:53
  while, especially SCR, since 2012. Over a decade
• 2:56
  now. Indeed. Getting clear, high -quality, comparative
• 2:59
  evidence has actually proven quite difficult.
• 3:02
  This meta -analysis tried to synthesize whatever
• 3:04
  was out there. OK, so methodology. How did they
• 3:06
  go about it? Searching databases, I assume? Yes.
• 3:09
  They searched the major medical databases covering
• 3:12
  a decade, 2013 up to 2023. Looking for studies
• 3:16
  comparing SCR and PR in these specific patients.
• 3:20
  Massive tiers. Failed non -off treatment. Exactly.
• 3:24
  They were open to various study designs, initially
• 3:26
  RCTs, cohort studies, etc. But what did they
• 3:29
  actually end up with after filtering everything?
• 3:32
  Well, they started with over a thousand potential
• 3:34
  articles, but after applying their strict inclusion
• 3:37
  criteria, sifting through, they ended up with
• 3:40
  a very small number of studies suitable for a
• 3:42
  direct comparison. How small are we talking?
• 3:45
  Critically small, really, for this kind of question.
• 3:47
  Just four studies met all the criteria for the
• 3:49
  final meta -analysis comparing SCR and PR. Only
• 3:53
  four. Out of more than a thousand possibilities,
• 3:55
  that does sound low. It is low, particularly
• 3:57
  given how common the condition is and that these
• 3:59
  procedures are being done. And what type of studies
• 4:01
  were they? This is really important. All four
• 4:03
  were cohort studies. No randomized controlled
• 4:05
  trials. None that met their criteria for pooling
• 4:08
  data comparing SCR and PR directly. So the entire
• 4:12
  analysis rests on observational cohort data.
• 4:14
  Which is generally considered a lower level of
• 4:17
  evidence for comparing treatments, isn't it?
• 4:19
  It is, yes, compared to RCTs. These four cohort
• 4:23
  studies, together, included a total of 235 patients.
• 4:27
  Okay, so 235 patients across four cohort studies.
• 4:31
  What did pooling that data actually show? What
• 4:33
  were the outcomes they looked at? They focused
• 4:35
  on a range of important outcomes. The primary
• 4:38
  one was the constant shoulder score. That's a
• 4:40
  standard measure for shoulder function and pain.
• 4:43
  Yes. Widely used and validated. Then they looked
• 4:46
  at secondary outcomes, too. Things like the DSH
• 4:49
  score. Disabilities of the arm, shoulder, and
• 4:51
  hand score? Patient reported. That's the one.
• 4:53
  Also the acromiohumeral distance, the space on
• 4:56
  x -ray between the arm bone and shoulder blade.
• 4:58
  Which can decrease in these big tears. Exactly.
• 5:00
  It can collapse. They also compared re -operation
• 5:02
  rates, forward flexion, how high you can lift
• 5:05
  your arm forward, and pain using the visual analog
• 5:07
  score, the VAS. Right, the crucial bit then,
• 5:10
  pooling those four studies, comparing SCR and
• 5:12
  PR across all those measures. What was the headline
• 5:15
  finding? And here's perhaps the most significant
• 5:18
  result. or maybe non -result, depending on how
• 5:21
  you look at it. Okay. The paper reported no statistically
• 5:24
  significant differences between the SCR group
• 5:26
  and the PR group for any of the primary or key
• 5:29
  secondary outcomes analyzed. None at all. Not
• 5:32
  for the constant score, D, A, H, A, H, D, re
• 5:35
  -operation, flexion, pain. No statistically significant
• 5:38
  differences found across the board based on the
• 5:40
  pooled data from these specific four studies.
• 5:43
  Neither technique showed a clear statistical
• 5:45
  advantage over the other. Wow. OK, that sounds
• 5:48
  quite definitive. No difference. But you flagged
• 5:51
  the low evidence level, the small number of studies.
• 5:54
  Does finding no statistically significant difference
• 5:57
  actually mean PR and SCR are proven to be equally
• 6:00
  good or equally bad? Ah, that's the crucial distinction.
• 6:04
  And it's vital not to jump to that conclusion.
• 6:07
  Finding no statistically significant difference
• 6:09
  here does not mean equivalence is proven. What
• 6:11
  it really means is that with the limited and
• 6:14
  variable evidence from these four cohort studies,
• 6:17
  there just wasn't enough statistical power or
• 6:20
  consistency to detect a significant difference,
• 6:23
  even if one truly exists. So it's less like saying
• 6:27
  they're identical and more like saying the data
• 6:29
  is too fuzzy or too sparse to tell them apart
• 6:32
  reliably. That's a very good way of putting it.
• 6:34
  You don't have enough evidence to declare a clear
• 6:37
  winner. The paper itself is very clear about
• 6:40
  this limitation. So inconclusive, really, not
• 6:43
  proof of sameness. Precisely. Inconclusive regarding
• 6:46
  superiority. And a major reason for that, as
• 6:49
  the authors point out, is the significant heterogeneity
• 6:52
  observed across the studies. Heterogeneity, meaning
• 6:55
  variability, differences between the studies.
• 6:57
  Exactly. Even though they pooled the data, the
• 7:00
  studies themselves were quite different in several
• 7:02
  ways, making a clean comparison difficult and
• 7:05
  limiting confidence in the pooled results. What
• 7:07
  sort of differences are we talking about? Where
• 7:08
  did this variability come from? Several places.
• 7:11
  Firstly, the patient populations weren't identical
• 7:13
  across the studies. How so? Well, some might
• 7:15
  have included patients with generally more severe
• 7:17
  characteristics to begin with. Others might have
• 7:20
  excluded patients with, say, diabetes or smoking
• 7:23
  history, but perhaps included those with pseudo
• 7:25
  -paralysis and really severe inability to lift
• 7:28
  the arm. These baseline differences can definitely
• 7:31
  influence outcomes, regardless of the surgery
• 7:34
  performed. That makes sense. Starting points
• 7:36
  matter. They absolutely do. And another critical
• 7:38
  source of variability was in the surgical techniques
• 7:41
  themselves, especially for SCR. Ah, you mentioned
• 7:44
  the original technique used a thick graft. Yes.
• 7:47
  The description by Dr. Mahata often considered
• 7:49
  the gold standard used a fairly thick 7 .5 millimeter
• 7:53
  autograft, usually fascia lata from the thigh.
• 7:56
  But the studies in this meta -analysis, they
• 7:59
  often use different materials and significantly
• 8:01
  thinner grafts. Thinner? Like what? Some use,
• 8:03
  for example, 3mm thick dermal allograft donor
• 8:07
  skin. Another used a 3mm porcine xenograft tissue
• 8:10
  from pigs. And a thinner graft might just not
• 8:13
  work the same way. Well, biomechanically, it
• 8:15
  might not provide the same level of stability
• 8:17
  or have the same properties as the thicker autograft.
• 8:21
  That could certainly lead to different results.
• 8:23
  And similarly, the partial repair techniques
• 8:25
  weren't identical either. Different ways of stitching,
• 8:29
  like margin convergence versus side -to -side
• 8:31
  repairs, could subtly change the mechanics. So
• 8:34
  the meta -analysis wasn't truly comparing one
• 8:37
  single SCR method to one single PR method. It
• 8:41
  was pooling data from studies using slightly
• 8:43
  different variations of both. That's exactly
• 8:46
  right. And that variation just adds noise to
• 8:48
  the analysis. OK. What else contributed to heterogeneity?
• 8:51
  inconsistencies in how outcomes were measured
• 8:53
  and reported. Ah, like using different scoring
• 8:56
  systems. Yes, or even slightly different versions.
• 8:59
  One study might use the standard constant score,
• 9:01
  another an age -adjusted version, another a quick
• 9:04
  DAESH. Someone else might use a totally different
• 9:06
  patient reported measure like the Western Ontario
• 9:08
  Rotator Cuff Index. Pulling data across different
• 9:12
  measurement tools introduces potential bias and
• 9:14
  reduces reliability. Right, comparing apples
• 9:17
  and oranges almost. A bit like that, yes. And
• 9:21
  then there were the methodological limitations
• 9:22
  of the studies themselves. Which were? Well,
• 9:25
  as we said, all four were retrospective cohort
• 9:28
  studies, looking back at existing data. Which
• 9:31
  means the surgeon chose the procedure for each
• 9:34
  patient, not random assignment. Correct. That
• 9:37
  carries an inherent risk of selection bias. Why
• 9:41
  did one patient get SCR and another PR? While
• 9:44
  they try to account for factors statistically,
• 9:46
  it's hard to eliminate that bias completely.
• 9:48
  And they were small studies too. Relatively small,
• 9:51
  yes, which limits statistical power. Plus, things
• 9:55
  like follow -up times weren't always uniform,
• 9:57
  and consistent post -op imaging wasn't always
• 10:00
  available for everyone, making it harder to assess
• 10:02
  graft healing or read tiers accurately. You mentioned
• 10:04
  the surgeon's choice. If the pooled outcomes
• 10:07
  look similar, what was driving the decision between
• 10:10
  SCR and PR in these particular studies? That's
• 10:12
  a key point the meta -analysis looked into. Based
• 10:15
  on these four studies, the main driver seemed
• 10:17
  to be the specific characteristics and severity
• 10:19
  of the tear itself. Things like how far the tendon
• 10:22
  had pulled back the retraction and the degree
• 10:25
  of fatty infiltration in the muscle, how much
• 10:28
  muscle had turned to fat because of the chronic
• 10:30
  tear. So it wasn't just surgeon preference. It
• 10:32
  was based on the tear's condition. According
• 10:35
  to what's reported here, yes. SCR tended to be
• 10:38
  chosen for the more advanced, genuinely irreparable
• 10:42
  situations. Where there was very little tendon
• 10:44
  left or it was too retracted or fatty to a pair.
• 10:48
  Exactly. where a partial repair wasn't really
• 10:51
  feasible. PR was selected when there were still
• 10:53
  components that could be repaired meaningfully,
• 10:56
  perhaps in large tiers, but with less severe
• 10:58
  retraction or fatty change. And things like age
• 11:01
  or gender didn't seem to be the deciding factor.
• 11:04
  The paper notes that those factors didn't appear
• 11:06
  to be significant drivers for choosing PR versus
• 11:09
  SCR in these specific study populations. That's
• 11:12
  really interesting. It suggests that even though
• 11:14
  the average outcomes in the pooled data didn't
• 11:16
  differ statistically, the two techniques might
• 11:19
  have been applied to groups with different baseline
• 11:21
  severities. That certainly appears to be the
• 11:23
  case from the studies analyzed here. One study
• 11:25
  specifically mentioned that complete tiers of
• 11:28
  another cuff muscle, the subscapularis and pseudo
• 11:31
  -paralysis, were more common in their SCR group.
• 11:35
  Suggesting more complex problems to start with.
• 11:37
  Potentially yes. Another showed more advanced
• 11:39
  tendon retraction in the SCR patients. So it
• 11:42
  does sound a bit like SCR was often being used
• 11:45
  for the hardest cases within this already difficult
• 11:48
  category of massive irreparable tiers. That's
• 11:51
  a reasonable interpretation based on the patient
• 11:53
  selection described in these papers. It reinforces
• 11:56
  that they weren't necessarily comparing like
• 11:58
  -for -like patient groups getting the different
• 11:59
  procedures. Did any of the individual studies
• 12:02
  report on things that couldn't be pooled, like,
• 12:04
  say, strength recovery? They did mention that.
• 12:07
  Some individual studies did measure other outcomes,
• 12:11
  specific strength tests, other ranges of motion
• 12:13
  like rotation or different scoring systems. And
• 12:16
  the authors note that one included study did
• 12:18
  suggest SCR might offer better post -op strength
• 12:21
  compared to PR. But because the data wasn't consistent
• 12:24
  across all four studies, it couldn't be reliably
• 12:27
  pooled and analyzed statistically in this meta
• 12:30
  -analysis, which just highlights another gap
• 12:32
  in the current evidence. OK, let's try and pull
• 12:34
  this all together then. This meta -analysis aimed
• 12:37
  to compare partial repair and superior capsular
• 12:40
  reconstruction for these big irreparable rotator
• 12:44
  cuff tears. Correct. Using studies from the last
• 12:47
  decade or so. And based on pooling data from
• 12:49
  just four cohort studies, no RCTs found comparing
• 12:53
  them directly covering 235 patients. The finding
• 12:57
  was no statistically significant difference between
• 13:00
  SCR and PR for the main outcome. constant score,
• 13:03
  or key secondary ones like DHH, HD, re -operation,
• 13:07
  flexion, or pain. And this is the really crucial
• 13:10
  point that lack of statistical difference does
• 13:12
  not prove they are equivalent. Absolutely not.
• 13:14
  The evidence level is low, it's only cohort studies,
• 13:16
  and there was significant variability, heterogeneity,
• 13:19
  across those studies. And that variability came
• 13:21
  from differences in the patients themselves,
• 13:23
  especially tear severity driving surgical choice.
• 13:26
  Variations in the actual surgical techniques
• 13:28
  used. particularly SCR graph type and thickness.
• 13:32
  Differences in how outcomes were measured and
• 13:34
  the general limitations of retrospective studies.
• 13:37
  Precisely. The analysis suggests SCR was often
• 13:39
  used for the tougher tiers based on retraction
• 13:42
  and fatty infiltration, not primarily based on
• 13:45
  age or gender in these studies. So the real takeaway
• 13:48
  isn't... PR and SCR are the same. It's more like,
• 13:52
  based on the limited variable evidence we currently
• 13:54
  have, we can't confidently say one is better
• 13:57
  and we really need better data. That sums it
• 14:00
  up perfectly. This study really underscores the
• 14:03
  current uncertainty in the evidence. It strongly
• 14:06
  supports the author's call for future high quality
• 14:08
  research. Specifically larger randomized controlled
• 14:11
  trials. Yes, well designed RCTs are needed to
• 14:14
  provide more robust evidence. And maybe those
• 14:17
  future trials could look at subgroups. Like comparing
• 14:19
  different ser graph types or outcomes based on
• 14:22
  initial fatty infiltration levels. Exactly. That
• 14:25
  kind of detailed high quality comparative data
• 14:27
  is what's needed to clarify the pros and cons
• 14:30
  of these approaches for different patient profiles.
• 14:33
  Because that could really help surgeons tailor
• 14:35
  the treatment better and improve outcomes. Absolutely.
• 14:38
  Without that stronger evidence, clinical decisions
• 14:41
  for these complex cases remain, well, less evidence
• 14:45
  based than we'd ideally like. It really makes
• 14:47
  you think, doesn't it? Even for common conditions
• 14:50
  and established procedures, figuring out the
• 14:53
  best approach absolutely depends on having good
• 14:56
  comparative evidence. It does. And sometimes
• 14:58
  the main finding of a study is simply highlighting
• 15:01
  where the evidence is weak and pointing the way
• 15:03
  for better research. If you found this deep dive
• 15:05
  useful, perhaps consider rating or sharing it.
• 15:08
  It helps others find this sort of discussion.
• 15:10
  A very important point. Recognizing the limits
• 15:13
  of current knowledge is always the first step
• 15:15
  towards asking the right questions to genuinely
• 15:17
  improve patient care in the future.